aNK (NK-92)

Drug identity checked against registry records

Also recorded as NK-92, Neukoplast

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)NCT02465957IBRXPhase 2Terminated2018-03-19Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.